#University of Colorado Cancer Center

An expert hopes to use gathered data to establish guidelines for how best to sample lymph nodes during surgery for pediatric kidney cancer.

Targeted therapies can reduce the size and number of brain metastases; patients could then have better-tolerated radiation therapy.

A multidisciplinary Colorado University team worked with Carolyn Degrafinried, and she now shows no evidence of pancreatic cancer.

I would have croaked eight years ago without leaping to new clinical trials, writes blogger and lung cancer survivor Dann Wonser.

Scientists answer the call in a nationwide effort to find out.

University of Colorado’s Adam Green, MD, aims to use research findings to help address disparities in childhood cancers.

After radiation, immunotherapy and chemo for melanoma, he tried an experimental therapy that uses TILs, tumor-infiltrating lymphocytes.

New mammogram regulations will improve early detection for women with dense breasts, say University of Colorado Cancer Center members.

University of Colorado researchers find that ulcerations could determine the risk of tumor recurrence and influence cancer treatment.

Luck, attitude and expertise add up to success for this Boulder businesswoman and pancreatic cancer patient.

Drugs developed to target particular genetic changes may not be right for every person whose cancer shows those alterations or mutations.

Thanks to groundbreaking immunotherapy research, Jane Hart enjoys every day without laryngeal cancer.

November is Pancreatic Cancer Awareness Month. Laura Foote shares her story to bring hope and express gratitude.

The Prostate Specific Membrane Antigen (PSMA) PET Scan more accurately locates cancerous cells and tumors, improving targeted treatments.

Despite confusing media coverage of a study relating to colonoscopies, they are an effective tool in reducing colorectal cancer risk.

Music teacher Winona Williams lives a life not dominated by her ovarian cancer diagnosis—and she hopes her treatment will help others.